These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 3778931

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin.
    Lijnen HR, Van Hoef B, Collen D.
    Eur J Biochem; 1987 Dec 01; 169(2):359-64. PubMed ID: 2961562
    [Abstract] [Full Text] [Related]

  • 3. Characterization of a fusion protein consisting of amino acids 1 to 263 of tissue-type plasminogen activator and amino acids 144 to 411 of urokinase-type plasminogen activator.
    Nelles L, Lijnen HR, Collen D, Holmes WE.
    J Biol Chem; 1987 Aug 05; 262(22):10855-62. PubMed ID: 2956260
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of the enhanced intrinsic activity of single-chain urokinase-type plasminogen activator during ongoing fibrinolysis.
    Fleury V, Lijnen HR, Anglés-Cano E.
    J Biol Chem; 1993 Sep 05; 268(25):18554-9. PubMed ID: 8103046
    [Abstract] [Full Text] [Related]

  • 5. Characterization of recombinant human single chain urokinase-type plasminogen activator mutants produced by site-specific mutagenesis of lysine 158.
    Nelles L, Lijnen HR, Collen D, Holmes WE.
    J Biol Chem; 1987 Apr 25; 262(12):5682-9. PubMed ID: 3106341
    [Abstract] [Full Text] [Related]

  • 6. Plasminogen activation with single-chain urokinase-type plasminogen activator (scu-PA). Studies with active site mutagenized plasminogen (Ser740----Ala) and plasmin-resistant scu-PA (Lys158----Glu).
    Lijnen HR, Van Hoef B, Nelles L, Collen D.
    J Biol Chem; 1990 Mar 25; 265(9):5232-6. PubMed ID: 1969415
    [Abstract] [Full Text] [Related]

  • 7. Characterization of a recombinant fusion protein of the finger domain of tissue-type plasminogen activator with a truncated single chain urokinase-type plasminogen activator.
    Gheysen D, Lijnen HR, Piérard L, de Foresta F, Demarsin E, Jacobs P, De Wilde M, Bollen A, Collen D.
    J Biol Chem; 1987 Aug 25; 262(24):11779-84. PubMed ID: 3114253
    [Abstract] [Full Text] [Related]

  • 8. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.
    Lijnen HR, Nelles L, Van Hoef B, Demarsin E, Collen D.
    Eur J Biochem; 1988 Nov 15; 177(3):575-82. PubMed ID: 2973984
    [Abstract] [Full Text] [Related]

  • 9. Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
    Barnathan ES, Kuo A, Rosenfeld L, Karikó K, Leski M, Robbiati F, Nolli ML, Henkin J, Cines DB.
    J Biol Chem; 1990 Feb 15; 265(5):2865-72. PubMed ID: 2154462
    [Abstract] [Full Text] [Related]

  • 10. Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.
    Lijnen HR, Nelles L, Van Hoef B, Demarsin E, Collen D.
    J Biol Chem; 1988 Dec 15; 263(35):19083-91. PubMed ID: 3143723
    [Abstract] [Full Text] [Related]

  • 11. Nerve growth factor-gamma activates soluble and receptor-bound single chain urokinase-type plasminogen activator.
    Wolf BB, Vasudevan J, Henkin J, Gonias SL.
    J Biol Chem; 1993 Aug 05; 268(22):16327-31. PubMed ID: 8393859
    [Abstract] [Full Text] [Related]

  • 12. Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA).
    Nelles L, Lijnen HR, Van Nuffelen A, Demarsin E, Collen D.
    Thromb Haemost; 1990 Aug 13; 64(1):53-60. PubMed ID: 2148847
    [Abstract] [Full Text] [Related]

  • 13. Characterization of plasminogen activation by glycosylphosphatidylinositol-anchored urokinase.
    Lee SW, Ellis V, Dichek DA.
    J Biol Chem; 1994 Jan 28; 269(4):2411-8. PubMed ID: 8300567
    [Abstract] [Full Text] [Related]

  • 14. Kinetics of plasmin activation of single chain urinary-type plasminogen activator (scu-PA) and demonstration of a high affinity interaction between scu-PA and plasminogen.
    Longstaff C, Clough AM, Gaffney PJ.
    J Biol Chem; 1992 Jan 05; 267(1):173-9. PubMed ID: 1730585
    [Abstract] [Full Text] [Related]

  • 15. The differential glycosylation of human pro-urokinase from various recombinant mammalian cell lines does not affect activity and binding to PAI-1.
    Sarubbi E, Nolli ML, Robbiati F, Soffientini A, Parenti F, Cassani G.
    Thromb Haemost; 1989 Nov 24; 62(3):927-33. PubMed ID: 2512681
    [Abstract] [Full Text] [Related]

  • 16. Characterization of a chimaeric plasminogen activator obtained by insertion of the second kringle structure of tissue-type plasminogen activator (amino acids 173 through 262) between residues Asp130 and Ser139 of urokinase-type plasminogen activator.
    Lijnen HR, Piérard L, Reff ME, Gheysen D.
    Thromb Res; 1988 Dec 01; 52(5):431-41. PubMed ID: 3146822
    [Abstract] [Full Text] [Related]

  • 17. Transformation-dependent activation of urokinase-type plasminogen activator by a plasmin-independent mechanism: involvement of cell surface membranes.
    Berkenpas MB, Quigley JP.
    Proc Natl Acad Sci U S A; 1991 Sep 01; 88(17):7768-72. PubMed ID: 1652763
    [Abstract] [Full Text] [Related]

  • 18. Purification and characterization of a novel low molecular weight form of single-chain urokinase-type plasminogen activator.
    Stump DC, Lijnen HR, Collen D.
    J Biol Chem; 1986 Dec 25; 261(36):17120-6. PubMed ID: 3097021
    [Abstract] [Full Text] [Related]

  • 19. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding.
    Jiao J, Yu M, Ru B.
    Biochim Biophys Acta; 2001 Apr 07; 1546(2):399-405. PubMed ID: 11295444
    [Abstract] [Full Text] [Related]

  • 20. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
    Ugwu F, Van Hoef B, Bini A, Collen D, Lijnen HR.
    Biochemistry; 1998 May 19; 37(20):7231-6. PubMed ID: 9585535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.